• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 3. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 4. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Hydrazines and derivatives Alkylhydrazines

Hydrazine, (1-methylpropyl)- (CAS No. 30924-14-2): A Comprehensive Overview of Its Chemical Properties and Emerging Applications

Hydrazine, (1-methylpropyl)-, identified by the Chemical Abstracts Service registry number CAS No. 30924-14-2, is a significant organic compound that has garnered considerable attention in the field of chemical and pharmaceutical research. This compound, characterized by its molecular formula C?H??N?, belongs to the hydrazine derivatives family, which are known for their versatile reactivity and utility in various synthetic pathways. The presence of the (1-methylpropyl) group in its structure imparts unique chemical properties that make it a valuable intermediate in the synthesis of more complex molecules.

The structural configuration of Hydrazine, (1-methylpropyl)- involves a central hydrazine core connected to an isobutyl group. This arrangement contributes to its distinct reactivity, particularly in nucleophilic substitution reactions and as a precursor in the formation of heterocyclic compounds. The compound’s solubility in polar organic solvents such as ethanol and dimethyl sulfoxide (DMSO) further enhances its applicability in laboratory-scale reactions and industrial processes.

In recent years, the study of hydrazine derivatives has seen significant advancements, particularly in their role as intermediates in pharmaceutical synthesis. Research has highlighted the potential of compounds like Hydrazine, (1-methylpropyl)- in the development of novel therapeutic agents. For instance, studies have demonstrated its utility in the synthesis of hydrazinoalkanes, which are being explored for their antimicrobial and anti-inflammatory properties. The compound’s ability to participate in Michael addition reactions makes it a promising candidate for constructing more complex molecular frameworks essential for drug design.

The pharmaceutical industry has been particularly interested in leveraging the reactivity of Hydrazine, (1-methylpropyl)- to develop new classes of drugs. Researchers have reported its incorporation into heterocyclic scaffolds that exhibit significant biological activity. For example, derivatives of this compound have been investigated for their potential as kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The structural flexibility offered by the (1-methylpropyl) group allows for modifications that can fine-tune the pharmacokinetic properties of these derivatives, making them more effective in vivo.

Moreover, the chemical community has recognized the importance of Hydrazine, (1-methylpropyl)- in materials science applications. Its reactivity with metal ions has been exploited to develop novel catalysts and coordination complexes that exhibit enhanced catalytic performance. These complexes are being studied for their potential use in industrial catalytic processes, where they could improve efficiency and reduce environmental impact. The ability of this compound to form stable bonds with transition metals makes it an attractive candidate for designing advanced materials with tailored properties.

The synthesis of Hydrazine, (1-methylpropyl)- is another area where significant progress has been made. Modern synthetic methodologies have enabled more efficient and scalable production processes, reducing costs and improving yields. Techniques such as catalytic hydrogenation and cross-coupling reactions have been employed to streamline its synthesis from readily available starting materials. These advancements have not only made the compound more accessible but also opened new avenues for its application in diverse chemical transformations.

The safety profile of Hydrazine, (1-methylpropyl)- is another critical aspect that has been thoroughly investigated. While hydrazine derivatives are known for their reactivity, proper handling protocols ensure that risks are minimized during storage and use. Research has focused on understanding its toxicological effects and developing guidelines for safe laboratory practices. These efforts have led to improved safety measures that protect researchers while allowing for continued exploration of its potential applications.

In conclusion, Hydrazine, (1-methylpropyl)- represents a fascinating compound with a wide range of applications across multiple scientific disciplines. Its unique chemical properties make it a valuable intermediate in pharmaceutical synthesis, materials science, and industrial catalysis. As research continues to uncover new uses for this compound, its significance is expected to grow further. The ongoing development of innovative synthetic methods and safety protocols ensures that it remains a cornerstone in both academic research and industrial applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)